Beyond the weight: how obesity drugs and bariatric surgery are changing cardiovascular medicine

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Carel le Roux from University College, Dublin and Ulster University. They discuss the trial evidence that has emerged over the last 20 years for both bariatric surgery and the newer GLP-1 medications, focusing particularly on reductions in cardiovascular outcomes. They also discuss where the field of obesity intervention might head over the next five years and how metabolic surgery will continue to have an important role. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper: https://heart.bmj.com/content/early/2026/02/23/heartjnl-2025-326812